Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints. - Reilly MM; Herrmann DN; Pareyson D; Scherer SS; Finkel RS; Züchner S; Burns J; Shy ME (Annals of neurology, 2023)